WILL MCLEAN, Ph.D.
Co-founder and Vice President, Biology and Regenerative Medicine
Will is the Vice President of Biology and Regenerative Medicine and a Co-founder of Frequency Therapeutics. His scientific strategy leadership role at Frequency Therapeutics is backed by his expertise in stem cell biology, hearing, and neuroscience. During his doctoral research at MIT, Will elucidated the different stem cell types that exist within the inner ear. He later completed his post-doctoral studies at Harvard Medical School. Will’s hearing research has been published in multiple peer reviewed and invited journals, including the Journal of the Association for Research in Otolaryngology, Development, PLOS ONE, and Audiology Today. He was awarded the Harvard-MIT IDEA2 award for high-impact translational research and was an MIT $100K finalist. Will has also been named to the MIT Technology Review 35, the 35 innovators under 35 most likely to impact technology, and the Hartford Business Journal 40 under 40. Will earned a Ph.D. from the Harvard-MIT Health Science and Technology Program within MIT and a B.S. in Biology from Tufts University.